Showing results (1-10 of 525) with videos related to
Sort By:
Pageof 53
Therapeutic Advances in Drug Safety|April 30, 2015
Abuse-deterrent formulations: transitioning the pharmaceutical market to improve public health and safetyKyle Simon, Stacey L Worthy, Michael C Barnes, et al.Therapeutic Advances in Drug Safety|January 11, 2018
Precision medicine: does ethnicity information complement genotype-based prescribing decisions?Rashmi R Shah, Andrea GaedigkTherapeutic Advances in Drug Safety|March 30, 2018
A threshold trajectory was revealed by isolating the effects of hemoglobin rate of rise in anemia of chronic kidney diseaseGregory Fusco, Ali Hariri, Carlos Vallarino, et al.Therapeutic Advances in Drug Safety|December 15, 2018
Psychiatric outcomes observed in patients living with HIV using six common core antiretrovirals in the Observational Pharmaco-Epidemiology Research and Analysis databaseRicky Hsu, Jennifer Fusco, Cassidy Henegar, et al.Therapeutic Advances in Drug Safety|December 15, 2018
Deprescribing conversations: a closer look at prescriber-patient communicationJustin P Turner, Claude Richard, Marie-Thérèse Lussier, et al.Therapeutic Advances in Drug Safety|May 6, 2021
Petroselinum crispum, a commonly consumed food, affects sirolimus level in a renal transplant recipient: a case reportMelek Kurtaran, Neriman Sila Koc, Melek Seren Aksun, et al.Therapeutic Advances in Drug Safety|May 22, 2020
Self-administration of medication: a pragmatic randomized controlled trial of the impact on dispensing errors, perceptions, and satisfactionCharlotte Arp Sørensen, Marianne Lisby, Charlotte Olesen, et al.Therapeutic Advances in Drug Safety|April 22, 2020
Practical applications of regulatory requirements for signal detection and communications in pharmacovigilanceMarina A MalikovaTherapeutic Advances in Drug Safety|August 9, 2021
Patient harm from cardiovascular medicationsChariclia Paradissis, Neil Cottrell, Ian Coombes, et al.Therapeutic Advances in Drug Safety|August 25, 2022
Patients' attitudes toward deprescribing and their experiences communicating with clinicians and pharmacistsKaylee M Lukacena, James W Keck, Patricia R Freeman, et al.Pageof 53